Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies
Katharina Dendl, Rebecca Finck, Frederik L. Giesel, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 2, pp. 721-731
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
Yuriko Mori, Katharina Dendl, Jens Cardinale, et al.
Radiology (2023) Vol. 306, Iss. 2
Closed Access | Times Cited: 185
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4946-4946
Open Access | Times Cited: 113
FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
Rong Huang, Yu Pu, Shun Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71
First Clinical Experience of 68Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Ula Al-Rasheed, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 218-218
Open Access | Times Cited: 2
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms
Emilia Fortunati, Giulia Argalia, Lucia Zanoni, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 5, pp. 703-720
Open Access | Times Cited: 46
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1023-1023
Open Access | Times Cited: 47
Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer
Emil Novruzov, Katharina Dendl, Honest Ndlovu, et al.
Molecular Imaging and Biology (2022) Vol. 24, Iss. 4, pp. 651-658
Open Access | Times Cited: 32
Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
Aleksander Kosmala, Sebastian E. Serfling, Wiebke Schlötelburg, et al.
Clinical Nuclear Medicine (2022) Vol. 48, Iss. 1, pp. 35-42
Open Access | Times Cited: 29
First Total-Body Kinetic Modeling and Parametric Imaging of Dynamic68Ga-FAPI-04 PET in Pancreatic and Gastric Cancer
Ruohua Chen, Xinlan Yang, Yee Ling Ng, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 6, pp. 960-967
Open Access | Times Cited: 22
The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
Yanzhao Dong, Haiying Zhou, Ahmad Alhaskawi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1193-1193
Open Access | Times Cited: 22
FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
Tianshuo Yang, Long Ma, Haodong Hou, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 26
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
Lena M. Unterrainer, Simon Lindner, Lennert Eismann, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 10, pp. 3571-3580
Open Access | Times Cited: 24
Molecular imaging Theranostics of Neuroendocrine Tumors
Emilia Fortunati, Norma Bonazzi, Lucia Zanoni, et al.
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 4, pp. 539-554
Closed Access | Times Cited: 16
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 6, pp. 888-896
Closed Access | Times Cited: 5
Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging
Ying Kou, Xuemei Jiang, Yutang Yao, et al.
Nuclear Medicine Communications (2022) Vol. 43, Iss. 7, pp. 847-854
Closed Access | Times Cited: 20
68Ga-FAPI PET/CT Provides a Clear Picture of a Klatskin Tumor That 18F-FDG PET/CT Missed
Akram Al‐Ibraheem, Soud Al-Qasem, Mousa El Khaldi, et al.
Clinical Nuclear Medicine (2023) Vol. 48, Iss. 6, pp. e313-e315
Closed Access | Times Cited: 12
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
Zeyu Zhang, Jinxin Tao, Jiangdong Qiu, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 361-381
Closed Access | Times Cited: 12
Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis
Rutger B. Henrar, Floris A. Vuijk, George L. Burchell, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1978-1978
Open Access
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging
Katharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Annals of Nuclear Medicine (2021) Vol. 36, Iss. 3, pp. 293-301
Open Access | Times Cited: 23
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies
Katharina Dendl, Stefan A. Koerber, Katharina Tamburini, et al.
Seminars in Nuclear Medicine (2022) Vol. 52, Iss. 5, pp. 628-634
Closed Access | Times Cited: 15
Benign lesions with 68Ga-FAPI uptake: a retrospective study
Qiaoqiao Shu, Yudi Wang, Maoxue Deng, et al.
British Journal of Radiology (2023) Vol. 96, Iss. 1144
Open Access | Times Cited: 9
[68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake
Haiyan Hong, Zhihao Zha, Ruiyue Zhao, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 4, pp. 2159-2169
Closed Access | Times Cited: 9
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
Laëtitia Vercellino, Dorine de Jong, Laurent Dercle, et al.
Diagnostics (2022) Vol. 12, Iss. 5, pp. 1116-1116
Open Access | Times Cited: 14
Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy
Francesco Bartoli, Philip H. Elsinga, Luiza Reali Nazario, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 958-958
Open Access | Times Cited: 12
Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements
Mardjan Dabir, Emil Novruzov, K. Mattes-György, et al.
Molecular Imaging and Biology (2022) Vol. 25, Iss. 2, pp. 324-333
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top